DK1351697T3 - Lægemiddel til fremme af regenerationen af væv - Google Patents

Lægemiddel til fremme af regenerationen af væv

Info

Publication number
DK1351697T3
DK1351697T3 DK02709881.3T DK02709881T DK1351697T3 DK 1351697 T3 DK1351697 T3 DK 1351697T3 DK 02709881 T DK02709881 T DK 02709881T DK 1351697 T3 DK1351697 T3 DK 1351697T3
Authority
DK
Denmark
Prior art keywords
regeneration
medicine
tissue
promote
Prior art date
Application number
DK02709881.3T
Other languages
English (en)
Inventor
Reinhard Gruber
Johann Eibl
Georg Watzek
Original Assignee
Georg Watzek
Reinhard Gruber
Bio Prod & Bio Eng Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Georg Watzek, Reinhard Gruber, Bio Prod & Bio Eng Ag filed Critical Georg Watzek
Application granted granted Critical
Publication of DK1351697T3 publication Critical patent/DK1351697T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4833—Thrombin (3.4.21.5)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/42—Phosphorus; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/363—Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Inorganic Chemistry (AREA)
  • Virology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK02709881.3T 2001-01-18 2002-01-17 Lægemiddel til fremme af regenerationen af væv DK1351697T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT892001 2001-01-18
PCT/AT2002/000018 WO2002056897A2 (de) 2001-01-18 2002-01-17 Arzneimittel zur förderung der regeneration von gewebe

Publications (1)

Publication Number Publication Date
DK1351697T3 true DK1351697T3 (da) 2014-01-20

Family

ID=3609637

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02709881.3T DK1351697T3 (da) 2001-01-18 2002-01-17 Lægemiddel til fremme af regenerationen af væv

Country Status (7)

Country Link
US (1) US20040082511A1 (da)
EP (1) EP1351697B1 (da)
CA (1) CA2435248A1 (da)
DK (1) DK1351697T3 (da)
ES (1) ES2444090T3 (da)
PT (1) PT1351697E (da)
WO (1) WO2002056897A2 (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT407484B (de) * 1997-11-12 2001-03-26 Bio Prod & Bio Eng Ag Arzneimittel zur förderung der wundheilung
US7842667B2 (en) 2003-12-22 2010-11-30 Regentis Biomaterials Ltd. Matrix composed of a naturally-occurring protein backbone cross linked by a synthetic polymer and methods of generating and using same
DK1722834T3 (da) * 2003-12-22 2012-10-22 Regentis Biomaterials Ltd Matrix, som omfatter naturligt forekommende tværbundet proteinskelet
DE102004018347A1 (de) * 2004-04-06 2005-10-27 Manfred Dr. Schmolz Wundheilungsfördende Botenstoffmischung
US8021847B2 (en) 2004-06-02 2011-09-20 Proxy Life Science Holdings, Inc. Microvesicle-based compositions and methods
WO2005121369A2 (en) * 2004-06-02 2005-12-22 Sourcepharm, Inc. Rna-containing microvesicles and methods therefor
WO2013169202A1 (en) * 2012-05-10 2013-11-14 Biomatcell Ab Osteogenic differentiation of mesenchymal stem cells
KR20200141080A (ko) 2018-04-09 2020-12-17 오르제네시스 인코포레이티드 바이옥솜 입자, 레독솜, 방법 및 조성물

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5185160A (en) * 1984-06-21 1993-02-09 Prp, Inc. Platelet membrane microvesicles
US5178883A (en) * 1984-11-29 1993-01-12 Regents Of The University Of Minnesota Method for promoting hair growth
US5165938A (en) * 1984-11-29 1992-11-24 Regents Of The University Of Minnesota Wound healing agents derived from platelets
DE3626110A1 (de) * 1986-08-01 1988-02-11 Peter Dr Terness Immunsuppressives serum
JP3064470B2 (ja) * 1991-04-19 2000-07-12 杉郎 大谷 人工補填補綴材料
US5552290A (en) * 1994-11-14 1996-09-03 University Of Massachusetts Medical Center Detection of procoagulant platelet-derived microparticles in whole blood
AT500670A1 (de) * 1999-05-19 2006-02-15 Bio & Bio Licensing Sa Arzneimittel zur lokalen anwendung

Also Published As

Publication number Publication date
PT1351697E (pt) 2013-12-24
US20040082511A1 (en) 2004-04-29
WO2002056897A3 (de) 2002-10-17
WO2002056897A2 (de) 2002-07-25
ES2444090T3 (es) 2014-02-24
EP1351697B1 (de) 2013-10-30
CA2435248A1 (en) 2002-07-25
EP1351697A2 (de) 2003-10-15

Similar Documents

Publication Publication Date Title
DK1663287T3 (da) Anvendelse af modificerede cyclosporiner til behandling af HCV-sygdomme
DK1944322T3 (da) Behandling af TNFalfa-relaterede sygdomme
DK1542748T3 (da) Engangssprøjte
DE60205514D1 (de) Wegwerfwindel
DK1803718T3 (da) 4-Tetrazolyl-4-phenylpiperidin-derivater til behandling af smerter
NO20025092L (no) Engangsspröyte
DE60312780D1 (de) Wegwerfwindel
NO20042154L (no) Terapeutiske isokinolinforbindelser
DE60223697D1 (de) Wegwerfwindel
DK1448205T3 (da) Kombinationer til behandling af immunoinflammatoriske sygdomme
ATE354360T1 (de) Amidoacetonitrile zur bekämpfung von endoparasiten
DK1282616T3 (da) Hydroxyphenylpiperidin-4-ylidenmethylbenzamidderivater til behandling af smerter
NO20033205D0 (no) Terapeutiske kromanforbindelser
DK1392318T3 (da) 15-keto-prostaglandiner til behandling af lægemiddelinduceret forstoppelse
NO20031565L (no) Engangsspröyte
DE50209245D1 (de) Neuroprotektives medikament
DK1727801T3 (da) Til behandling af smerter anvendelige piperaziner
NO20041968L (no) Anvendelse av cystationin
ATE365455T1 (de) Aminoacetonitril-verbindungen zur bekämpfung von endoparasiten
DE60220220D1 (de) Blutbehandlungssystem
DE60333439D1 (de) Herstellung von olefinen
DK1461042T3 (da) Anvendelse af desoxypeganin til behandling af klinisk depression
DE602004013599D1 (de) Herstellung von somatostatinpeptiden
DE60227896D1 (de) Verfahen zur Herstellung von Polyalkylphenoxyaminoalkanen
ITMI20011820A0 (it) Trattamento di ustioni